Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases
about
Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes.Exposure to animals and risk of oligoarticular juvenile idiopathic arthritis: a multicenter case-control studyDNA methylation signatures in cord blood associated with maternal gestational weight gain: results from the ALSPAC cohortUse of nonobese diabetic mice to understand human type 1 diabetesInvestigation of the functional variant c.-169T > C of the Fc receptor-like 3 (FCRL3) gene in alopecia areata.RUNX transcription factors: association with pediatric asthma and modulated by maternal smoking.Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy.Transcriptomic alterations in the heart of non-obese type 2 diabetic Goto-Kakizaki ratsGenetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and PolymorphismsADAM33 polymorphisms are associated with asthma and a distinctive palm dermatoglyphic pattern.Type 1 diabetes: etiology, immunology, and therapeutic strategies.Four FCRL3 Gene Polymorphisms (FCRL3_3, _5, _6, _8) Confer Susceptibility to Multiple Sclerosis: Results from a Case-Control Study.Healthy first-degree relatives of patients with type 1 diabetes exhibit significant differences in basal gene expression pattern of immunocompetent cells compared to controls: expression pattern as predeterminant of autoimmune diabetes.Fc receptor-like 3 (FCRL3) -169 C/T polymorphism and systemic lupus erythematosus: a meta-analysis.The Fc receptor-like 3 gene polymorphisms and susceptibility to autoimmune diseases: an updated meta-analysis.
P2860
Q33247790-6807A23B-6807-439D-BC46-4AF21C6742A8Q33307633-234BB63D-560E-4E9E-B566-DE10FABDFD17Q33559199-F609DD4E-F25C-41D0-B517-41DC8BB64298Q33938865-9958C29C-5610-4677-BFCF-3A67F6D4B189Q34078163-268C7F12-CA97-43C1-8A45-56E3527A2794Q34583300-F16FD9E7-1A9F-402A-AEEF-55B565BA6571Q35543588-873E405E-9DA3-4DCA-8A3F-5B9AC349D307Q36625351-F3E235A3-355D-4EF4-A7CF-22AB237DC98FQ37156557-6E354B0D-6E66-49AA-91D1-F27485C4792BQ37200819-D3E4B45F-EF88-4143-A0B0-DF93767D4F25Q37313302-21AE4333-B214-4A4D-A753-4BB06E8FE8B8Q37830198-9F3B9596-658F-490B-B770-46553A85B4E9Q39019331-EE3A1345-56CA-4FEC-99E6-5A4A1C3AB43BQ42494546-7DDA9E7E-ABF6-425D-9395-A38AD7B88C75Q53116634-C919A696-2A12-4E5B-97F3-2430C92795DFQ53127943-F240A96E-35F6-4C6F-8BF3-4D6DCB4EF2C8
P2860
Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Analysis of polymorphisms in 1 ...... other immune-mediated diseases
@ast
Analysis of polymorphisms in 1 ...... other immune-mediated diseases
@en
type
label
Analysis of polymorphisms in 1 ...... other immune-mediated diseases
@ast
Analysis of polymorphisms in 1 ...... other immune-mediated diseases
@en
prefLabel
Analysis of polymorphisms in 1 ...... other immune-mediated diseases
@ast
Analysis of polymorphisms in 1 ...... other immune-mediated diseases
@en
P2093
P2860
P50
P356
P1433
P1476
Analysis of polymorphisms in 1 ...... other immune-mediated diseases
@en
P2093
Adrian Vella
Alex C Lam
Christopher E Lowe
Jason D Cooper
Joanna M M Howson
John S Hulme
Kieran Holland
Lisa M Maier
Rebecca Bailey
Rebecca C J Twells
P2860
P2888
P356
10.1186/1471-2350-7-20
P577
2006-03-06T00:00:00Z
P5875
P6179
1011369883